Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Axitinib
Related studies linked through entity extraction aliases.
Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England
- Status
- COMPLETED
- Phase
- N/A
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NPC - AXEL Study : Axitinib-Avelumab
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
- Status
- RECRUITING
- Phase
- PHASE2
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab With Axitinib in Recurrent Endometrial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.
- Status
- COMPLETED
- Phase
- N/A
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- NA
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2